New Drug Approved For Advanced Basal Cell Carcinoma
Comments : 1
The Food and Drug Administration in the United States approved the first drug to treat the most common form of skin cancer, Basal Cell Carcinoma. It can be used as an alternative for patients who can’t have surgery or radiation treatments. It is also used in patients with skin cancer that has spread elsewhere in the body.
That is a great news for the Canadian and American patients suffering from challenging basal cell carcinomas. Ask your dermatologist for available skin cancer treatment options.